Taken together, ginger presents the potential as an alternative therapeutic agent to treat COVID-19. Therefore, we conducted a clinical trial to examine the effect of the ginger supplement on the clinical manifestations of individuals with COVID-19.The study protocol was approved by the institutional review boards of Zhongshan Hospital, Fudan University, and the trial was registered on the Chinese Clinical Trial Registry . All participants provided written informed consent.
. Except for a relatively higher proportion of individuals with hypertension in the control group , the sex and age distribution and other basic health conditions were the similar between two groups.The ginger-supplemented group showed a significantly shorter hospitalization time compared with the control (6.0 vs. 8.5 d,